Skip to main content
. 2010 Jun 3;1(3):156–165. doi: 10.1007/s12672-010-0016-8

Table 1.

Demographic and tumor characteristics of breast cancer cases by histologic type

Characteristic Ductal n = 255,718 Ductal-lobular n = 26,900 Lobular n = 21,062 Mucinous n = 6,561 Tubular n = 4,477 Inflammatory n = 2,673 Medullary n = 2,072
n % n % n % n % n % n % n %
Age at diagnosis, years
 30–39 15,959 6.2 1,075 4.0 402 1.9 227 3.5 88 2.0 253 9.5 296 14.3
 40–49 52,012 20.3 5,251 19.5 3,218 15.3 811 12.4 784 17.5 587 22.0 648 31.3
 50–59 64,076 25.1 7,173 26.7 4,973 23.6 1,018 15.5 1,295 28.9 778 29.1 556 26.8
 60–69 55,036 21.5 6,171 22.9 5,084 24.1 1,331 20.3 1,167 26.1 510 19.1 329 15.9
 70–79 45,123 17.6 4,926 18.3 4,700 22.3 1,895 28.9 833 18.6 337 12.6 173 8.3
 80+ 23,512 9.2 2,304 8.6 2,685 12.7 1,279 19.5 310 6.9 208 7.8 70 3.4
 Mean ± standard deviation 59.7 ± 13.9 60.4 ± 13.1 63.5 ± 13.2 66.5 ± 14.2 60.8 ± 12.0 57.3 ± 13.9 52.8 ± 12.8
Year of diagnosis
 1992–1995 32,125 12.6 1,954 7.3 1,593 7.6 559 8.5 433 9.7 354 13.2 410 19.8
 1996–1999 44,166 17.3 3,868 14.4 3,233 15.3 1,038 15.8 861 19.2 536 20.1 422 20.4
 2000–2003 84,495 33.0 10,462 38.9 7,142 33.9 2,331 35.5 1,719 38.4 1125 42.1 678 32.7
 2004–2007 94,932 37.1 10,616 39.5 9,094 43.2 2,633 40.1 1,464 32.7 658 24.6 562 27.1
 Mean follow-up time ± standard deviation, months 61.0 ± 46.1 57.8 ± 40.6 54.7 ± 41.6 58.8 ± 42.2 67.9 ± 43.5 40.2 ± 35.7 76.3 ± 50.3
SEER registry
 Alaska natives 329 0.1 37 0.1 21 0.1 5 0.1 1 0.0 4 0.1 5 0.2
 Atlanta 12,350 4.8 772 2.9 695 3.3 211 3.2 155 3.5 126 4.7 77 3.7
 Connecticut 17,624 6.9 2,060 7.7 1,683 8.0 467 7.1 334 7.5 148 5.5 206 9.9
 Detroit 17,481 6.8 1,771 6.6 1,439 6.8 355 5.4 303 6.8 101 3.8 174 8.4
 Greater California 45,584 16.5 5,442 20.2 4,010 19.0 1,164 17.7 714 15.9 534 20.0 257 12.4
 Hawaii 7,219 2.8 265 1.0 339 1.6 211 3.2 126 2.8 24 0.9 38 1.8
 Iowa 16,633 6.5 1,087 4.0 1,358 6.4 399 6.1 241 5.4 168 6.3 134 6.5
 Kentucky 9,316 3.6 692 2.6 767 3.6 223 3.4 162 3.6 112 4.2 41 2.0
 Los Angeles 30,517 11.9 4,988 18.5 2,419 11.5 1,005 15.3 736 16.4 591 22.1 449 21.7
 Louisiana 9,609 3.8 503 1.9 620 2.9 245 3.7 127 2.8 100 3.7 78 3.8
 New Jersey 21,752 8.5 2,480 9.2 1,864 8.9 492 7.5 329 7.3 150 5.6 140 6.8
 New Mexico 6,739 2.6 556 2.1 594 2.8 171 2.6 110 2.5 82 3.1 56 2.7
 Rural Georgia 457 0.2 31 0.1 31 0.1 10 0.2 5 0.1 6 0.2 7 0.3
 San Francisco-Oakland 22,238 8.7 1,930 7.2 1,738 8.3 497 7.6 356 8.0 192 7.2 125 6.0
 San Jose-Monterey 10,534 4.1 810 3.0 668 3.2 193 2.9 135 3.0 73 2.7 37 1.8
 Seattle-Puget Sound 23,213 9.1 2,613 9.7 2,212 10.5 726 11.1 566 12.6 166 6.2 157 7.6
 Utah 7,423 2.9 863 3.2 604 2.9 187 2.9 77 1.7 96 3.6 91 4.4
Race/ethnicity
 Non-Hispanic white 200,233 78.3 22,420 83.3 18,186 86.3 5,152 78.5 4,028 90.0 1960 73.3 1325 63.9
 African American 21,790 8.5 1,561 5.8 1,126 5.3 469 7.1 159 3.6 321 12.0 400 19.3
 Asian/Pacific Islander 18,164 7.1 1,437 5.3 819 3.9 599 9.1 156 3.5 115 4.3 128 6.2
 Hispanic white 12,445 4.9 1,282 4.8 780 3.7 271 4.1 103 2.3 252 9.4 195 9.4
 American Indian/Alaska Native 1,826 0.7 86 0.3 70 0.3 43 0.7 24 0.5 9 0.3 7 0.3
 Other 1,260 0.5 114 0.4 81 0.4 27 0.4 7 0.2 16 0.6 17 0.8
AJCC stage
 I 124,108 48.5 11,894 44.2 8,398 39.9 4,311 65.7 4,080 90.5 0 0.0 745 36.0
 II 102,332 40.0 11,621 43.2 9,016 42.8 1,962 29.9 398 8.9 0 0.0 1211 58.4
 III 20,678 8.1 2,680 10.0 2,835 13.5 205 3.1 18 0.4 2129 79.6 99 4.8
 IV 8,600 3.4 705 2.6 813 3.9 83 1.3 11 0.2 544 20.4 17 0.8
Grade
 1 43,704 17.1 5,235 19.5 5,658 26.9 3,850 58.7 3,971 88.7 43 1.6 22 1.1
 2 105,856 41.4 14,624 54.4 11,610 55.1 2,294 35.0 456 10.2 579 21.7 152 7.3
 3 101,309 39.6 6,649 24.7 3,443 16.7 385 5.9 49 1.1 1894 70.9 1721 83.1
 4 4,849 1.9 392 1.5 351 16.3 32 0.5 1 0.0 157 5.9 177 8.5
Tumor size, cm
 <2.0 144,431 56.5 14,523 54.0 9,430 44.8 4,127 62.9 4,232 94.5 50 1.9 783 37.8
 2.0–4.9 90,069 35.2 9,676 36.0 8,018 38.1 2,012 30.7 211 4.7 203 7.6 1158 55.9
 5.0+ 18,116 7.1 2,397 8.9 3,282 15.6 390 5.9 27 0.6 2248 84.1 120 5.8
 Missing 3,102 1.2 304 1.1 332 1.6 32 0.5 7 0.2 172 6.4 11 0.5
Nodal status
 Negative 163,976 64.1 16,003 59.5 12,737 60.5 5,785 88.2 4,184 93.5 310 11.6 1459 70.4
 Positive 87,936 34.4 10,613 39.5 7,996 38.0 706 10.8 283 6.3 2002 74.9 604 29.2
 Missing 3,806 1.5 284 1.1 329 1.6 70 1.1 10 0.2 361 13.5 9 0.4
ER/PR status
 ER+/PR+ 160,943 62.9 21,258 79.0 16,206 76.9 5,509 84.0 3,656 81.7 969 36.3 226 10.9
 ER+/PR− 31,070 12.2 3,616 13.4 3,605 17.1 833 12.7 669 14.9 357 13.4 134 6.5
 ER−/PR+ 5,374 2.1 316 1.2 279 1.3 33 0.5 58 1.3 126 4.7 75 3.6
 ER−/PR− 58,331 22.8 1,710 6.4 972 4.6 186 2.8 94 2.1 1221 45.7 1637 79.0
Surgical treatment
 None 6,156 2.4 411 1.5 523 2.5 97 1.5 25 0.6 420 15.7 10 0.5
 Breast conserving surgery 145,949 57.1 13,723 51.0 9,636 48.5 4,270 65.1 3,690 82.4 190 7.1 1331 64.2
 Total mastectomy 103,613 40.5 12,766 47.5 10,903 51.8 2,194 33.4 762 17.0 2063 77.2 731 35.3
Radiation treatment
 None 118,659 46.4 13,065 48.6 10,524 50.0 3,082 47.0 1,600 35.7 1177 44.0 894 43.1
 Treated with radiation 137,059 53.6 13,835 51.4 10,538 50.0 3,479 53.0 2,877 64.3 1496 56.0 1178 56.9
% of population in county living below 200% of the federal poverty level in the year 2,000 quartiles
 ≥36.31% 57,646 22.5 7,139 26.5 4,384 20.8 1,673 25.5 1,100 24.6 964 36.1 640 30.9
 26.96–36.30% 61,122 23.9 6,068 22.6 5,059 24.0 1,535 23.4 996 22.2 572 21.4 505 24.4
 19.61–26.95% 67,108 26.2 6,454 24.0 5,570 26.4 1,776 27.1 1,064 23.8 619 23.2 454 21.9
 ≤19.60% 69,842 27.3 7,239 26.9 6,049 28.7 1,577 24.0 1,317 29.4 518 19.4 473 22.8